medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Mirikizumab is associated with improvements in bowel urgency and quality of life in moderately-to-severely active ulcerative colitis: 28-week phase 3b results from the LUCENT-URGE trial. Crohns Colitis 360 Long M, Laharie D, Rogler G, Navabi S, Vadhariya A, Eastman WJ, Tian T, Bleakman AP, Armuzzi A. PMID: 42927097 [PubMed]
	Endoscopic and Histopathological Characteristics of Newly Diagnosed Crohn's Disease in Vietnam: Insights From a Tertiary IBD Center. JGH Open Dinh TH, Dang LM, Nguyen CD, Vo DT, Vo TD, Bui HH, Quach DT. PMID: 42927010 [PubMed]
	Noninfectious skin lesions in Crohn's disease patients treated with ustekinumab: a multicenter observational retrospective GETAID study. J Crohns Colitis Piga G, Amiot A, Bonnet J, Villani AP, Boschetti G, Gay C, Charlois AL, Benezech A, Hébuterne X, Laharie D, Peyrin-Biroulet L, Nancey S. PMID: 42926194 [PubMed - indexed for MEDLINE]
	Baicalin and levofloxacin exert divergent modulation on gut microbiota and metabolome crosstalk in DSS-triggered ulcerative colitis. Microbiol Spectr Wang C, Wu W, Cui M, Zhang S, Wang C. PMID: 42925028 [PubMed - as supplied by publisher]
	Creatine Supplementation in Crohn's Disease: Possible Therapeutic Trends in Symptoms and Muscle Tissue Integrity. Muscles Papadimitriou K, Kreider RB, Deligiannidou GE, Giaginis C, Papadopoulou SK. PMID: 42924643 [PubMed]
	Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeuticÂ implications (Review). Int J Mol Med Zhang T, Ren Z, Wang L, Man R, Wang L, Wang J, Cheng X, Peng J, Yu Y. PMID: 42924590 [PubMed - indexed for MEDLINE]
	Chinese herbal medicine for ulcerative colitis: product-level clinical evidence, mechanistic appraisal, and a roadmap to precision translation. Front Pharmacol Wu Y, Ren J, Li H, Qi S, Ke W. PMID: 42923132 [PubMed]
	Diagnosis and treatment of Crohn's disease with strong activity and rapid progression in the general surgery department. Wiad Lek Prykhidko RA, Krasnov OH, Kravtsiv MI, Ivashchenko DM, Zaiets SM. PMID: 42922330 [PubMed - indexed for MEDLINE]
	Epidemiological Evidence, Underlying Mechanisms, and Public Health Implications of Ultra-Processed Food Consumption in Inflammatory Bowel Disease. J Vis Exp Zhang H. PMID: 42921781 [PubMed - indexed for MEDLINE]
	Gut microbiota-mediated tryptophan metabolic dysregulation in the comorbidity of inflammatory bowel disease and autism spectrum disorder: mechanisms and research progress. Front Immunol Lu M, Chen Y, Zhou H, Lin Y. PMID: 42920990 [PubMed - indexed for MEDLINE]
	Microbiota-host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicine. Front Pharmacol Chen J, Du J, Mu B, Zhang J, Shang G, Yan X. PMID: 42920884 [PubMed]
	Robotic vs. laparoscopic IPAA in a high-volume referral centre: a retrospective observational study. J Robot Surg Galletto G, Violante T, Cardelli S, Calini G, Cuicchi D, Rottoli M. PMID: 42920002 [PubMed - indexed for MEDLINE]
	Chia seed oil attenuates titanium dioxide nanoparticles-induced ulcerative colitis in rats through suppression of NLRP3 inflammasome pathway "Histological and Molecular Study". J Mol Histol Sarhan NR, Shrief AI, Elmowafy R, Elekhtiar SA. PMID: 42919997 [PubMed - indexed for MEDLINE]
	Latent profile analysis of fertility motivation in women with inflammatory bowel disease: a cross-sectional study. BMC Womens Health Wang Y, Chen Y, Dong Q, Gao X, Jiang B. PMID: 42919338 [PubMed - indexed for MEDLINE]
	[New data on appendectomies for ulcerative colitis]. MMW Fortschr Med Gross M. PMID: 42919070 [PubMed - in process]
	Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians. J Crohns Colitis Con D, Li Wai Suen C, Choy M, Flegg JA, De Cruz P. PMID: 42918627 [PubMed - indexed for MEDLINE]
	Exploration of international differences in preoperative characteristics, indications, postoperative management and endoscopic recurrence rates in patients with Crohn's disease following ileocolic (re-)resection: first outcomes from the IMPACT consortium. J Crohns Colitis Bak MTJ, Hammoudi N, Lee SH, Maggiori L, van Ruler O, Bezault M, Hernandez-Rocha C, de Vries AC, Silverberg MS, Allez M, IMPACT (International Multidisciplinary Research Collaboration on Postoperative IBD) consortium; on behalf of the Dutch Initiative on Crohn and Colitis and the RAP-CD study group; on behalf of the NIDDK Inflammatory Bowel Disease Genetics Consortium; on behalf of the REMIND study group. PMID: 42918626 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Guselkumab in Patients with Crohn's Disease and Ulcerative Colitis: A Prospective Real-World Study. Clin Gastroenterol Hepatol Shafrir A, Choi D, Capucci LC, Hannett A, Tanouye J, Mathew AJ, Natt N, Dalal S, McDonald BD, Cleveland NK, Pekow J, Choden T, Cohen RD, Rubin DT. PMID: 42913902 [PubMed - as supplied by publisher]
	A real-world study of healthcare resource utilization and costs in patients with Crohn's disease and ulcerative colitis initiating ustekinumab treatment via Johnson & Johnson's BIOADVANCE program. Crohns Colitis 360 Targownik L, Pone E, Latour MG, Boyerahmadi K, Yang H, Ling J, Tehrani A, Golden S, Marshall JK. PMID: 42910390 [PubMed]
	Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis de la Croix H, Åberg H, Fledsberg S, Park J, Bengtsson J, Hermanson M. PMID: 42909622 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 59202

Seite 1 von 2961



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung